Joint Formulary & PAD

Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Search

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A to Z of Drugs : E

Records returned : 159 (on 16 Jul 2025 at 18:03:10).

Show Icon and Status Keys

Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Non Formulary
Formulations :
  • Pessaries
  • Vaginal cream
Restrictions / Comments:

 
Links :
NFD1
SPC
Indication :
Status :
Green (see narrative)
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

Important
Specialist initiation and at least one month supply before transfer to primary care. Reserved for use where apixaban / rivaroxaban are not suitable
 
Links :
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important
Tensilon test for diagnosis
 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

Important
Restricted Antimicrobial - requires GUM Specialist approval
 
Links :
NHSE
R
SPC
Indication :
Status :
Red
Restrictions / Comments:

Important

Restricted Antimicrobial - requires GUM  Specialist Approval.

 
Links :
NHSE
R
SPC
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
NHSE
NICE
R
SPC
Indication :
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
NHSE
NICE
R
SPC
10. Elemental 028 Extra
Drug:
Elemental 028 Extra
(Condition specific ONS )
Indication :
Status :
Blue
Formulations :
  • Powder
Restrictions / Comments:

Important

Prescribe on advice from specialist e.g. dietitian 

 
Links :
Indication :
Status :
Blue
Formulations :
  • Liquid
Restrictions / Comments:

Important

Prescribe on advice from specialist e.g. dietitian 

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Tablets
Restrictions / Comments:

Important
Not 1st line. Generic sumatriptan, naratriptan, rizatripan, zolmitriptan are preferred.
 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
ICB
SPC
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

Important

Haematology use only - treating chronic immune thrombocytopenia as per NICE TA293.

 
Links :
Indication :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

Important
NHS England - specialist centres only
 
Links :
NHSE
SPC
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important
If a patient with diabetes were on insulin and on multiple other treatments, a discussion with the specialist team may be prudent prior to Empagliflozin initiation.
 
Links :
17. Empagliflozin
Drug:
Empagliflozin
(Antidiabetic drugs)
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Preferred
 
Links :
Indication :
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Tablets
Restrictions / Comments:

Important
Reserve combination products for patients in whom separate components are less appropriate. Existing patients would not be expected to change therapy unless appropriate to do so.
 
Links :
20. Emsogen
Drug:
Emsogen
(Condition specific ONS )
Indication :
Status :
Blue
Formulations :
  • Powder
Restrictions / Comments:

Important

Prescribe on advice from specialist e.g. dietitian 

 
Links :
Indication :
Status :
Red
Formulations :
  • Capsules
  • Oral solution
Restrictions / Comments:

Important
Restricted Antimicrobial - requires GUM Specialist approval
 
Links :
NHSE
R
SPC
Indication :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

Important
Restricted Antimicrobial - requires GUM Specialist approval
 
Links :
NHSE
R
SPC
Indication :
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

Important
Restricted Antimicrobial - requires GUM Specialist approval
 
Links :
NHSE
R
SPC
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

Important

For post-exposure prophylaxis (e.g. needlestick injuries), follow your organisation's protocols for referral and access. Use as recommended by BHIVA/BASHH guidelines.

 
Links :
NHSE
R
SPC
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

Important
Pre-exposure prophylaxis (PrEP) is available through Sexual Health clinics for people at risk. Use as recommended by BHIVA/BASHH guidelines
 
Links :
NHSE
R
SPC
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Oro-dispersible tablets
Restrictions / Comments:

Important
Only licensed for use in children.
 
Links :
Status :
See narrative
Formulations :
  • Oro-dispersible tablets
Restrictions / Comments:

Important

Not assessed for inclusion on the formulary. Contact pharmacy team for advice on making an application.

 
Links :
NFD2
SPC
Indication :
Status :
Green (see narrative)
Formulations :
  • Tablets
Restrictions / Comments:

Important
Preferred ACE inhibitor during breastfeeding (where an ACE inhibitor is appropriate)
 
Links :
30. EnergieShake
Drug:
EnergieShake
(Powdered ONS)
Indication :
Status :
Green (see narrative)
Formulations :
  • Powder
Restrictions / Comments:

Important

AYMES Shake is the preferred first line powder milkshake in Surrey Heartlands 

 
Links :
Indication :
Status :
Blue
Formulations :
  • Liquid
Restrictions / Comments:

Important

Prescribe on advice from specialist e.g. dietitian 

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Liquid
Restrictions / Comments:

Important

Altraplen Energy is the preferred second line 1.5kcal/ml supplement when required in primary care. Ready to drink supplements should only be prescribed if individual cannot prepare milkshake from powder.

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Semi-Solid
Restrictions / Comments:

 
Links :
Status :
Red
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

Important
Prescribe by brand. RSCH / SASH / ASPH = Inhixa brand
 
Links :
SPC
Status :
Red
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

Important
Prescribe by brand. RSCH / SASH / ASPH = Inhixa brand
 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

Important
Prescribe by brand. RSCH / SASH / ASPH = Inhixa brand
 
Links :
SPC
Status :
Blue
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

Important
Prescribe by brand. RSCH / SASH / ASPH = Inhixa brand Specialist initiation and at least one month supply before transfer to primary care (excluding obstetric and cancer patients)
 
Links :
SPC
Status :
Red
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

Important
Off-label use. Prescribe by brand: RSCH / SASH / ASPH = Inhixa brand
 
Links :
Off Label
SPC
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

 
Links :
40. Enshake
Drug:
Enshake
(High calorie milkshake powder)
Indication :
Status :
Blue
Formulations :
  • Powder
Restrictions / Comments:

Important

Prescribe on advice from specialist e.g. dietitian 

 
Links :
Indication :
Status :
Blue
Formulations :
  • Liquid
Restrictions / Comments:

Important

Prescribe on advice from specialist e.g. dietitian 

 
Links :
42. Ensure liquid
Drug:
Ensure liquid
(Milkshake style ONS)
Indication :
Status :
Non Formulary
Formulations :
  • Liquid
Restrictions / Comments:

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Liquid
Restrictions / Comments:

Important

Secondline ONS

Altrajuce is the Surrey Heartlands preferred fruit juice style ONS for primary care.

Only prescribe if individual dislikes milk or requires lactose free supplement.

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Liquid
Restrictions / Comments:

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Liquid
Restrictions / Comments:

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Liquid
Restrictions / Comments:

Important

Altraplen Energy is the preferred second line 1.5kcal/ml supplement when required in primary care. Ready to drink supplements should only be prescribed if individual cannot prepare milkshake from powder.

 
Links :
47. Ensure Shake
Drug:
Ensure Shake
(Powdered ONS)
Indication :
Status :
Green (see narrative)
Formulations :
  • Powder
Restrictions / Comments:

Important

AYMES Shake is the preferred first line powder milkshake in Surrey Heartlands 

 
Links :
48. Ensure TwoCal
Drug:
Ensure TwoCal
(High Protein ONS)
Indication :
Status :
Non Formulary
Formulations :
  • Liquid
Restrictions / Comments:

 
Links :
Indication :
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

Important
Preferred
Preferred COMT inhibitor
 
Links :
Indication :
Status :
Red
Formulations :
  • Oral solution
  • Tablets
Restrictions / Comments:

Important

RESTRICTED - requires Hepatologist Specialist approval

 
Links :
NHSE
NICE
R
SPC
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important
Hypotentsion reversal in spinal or epidural anaesthesia
 
Links :
SPC
Status :
Non Formulary
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

Important
Initiation restricted to cardiology. Transfer to primary care only after initiation and at least the first month supply from the specialist.
 
Links :
Indication :
Status :
Red
Formulations :
  • Intravenous injection (IV)
  • Subcutaneous injection (sc)
Restrictions / Comments:

Important

Heamatology team only. 
NOT for dialysis-induced anaemia - this is not commissoned from any Surrey Heartlands Trusts. 

 
Links :
R
SPC
Status :
Non Formulary
Restrictions / Comments:

Important

NHSE commissioned services only. This is NOT commissoned from any Surrey Heartlands Trusts. 

 
Links :
NHSE
SPC
Indication :
Status :
Red
Formulations :
  • Intravenous injection (IV)
  • Subcutaneous injection (sc)
Restrictions / Comments:

Important

Heamatology team only. 

RSFT and ASPH preferred product is Epoetin Zeta.
NOT for dialysis-induced anaemia - this is not commissoned from any Surrey Heartlands Trusts. 

 
Links :
R
SPC
Indication :
Status :
Red
Formulations :
  • Intravenous injection (IV)
  • Subcutaneous injection (sc)
Restrictions / Comments:

Important

Heamatology team only. 
NOT for dialysis-induced anaemia - this is not commissoned from any Surrey Heartlands Trusts. 

Symptomatic anaemia in MDS or chronic renal failure, adults receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma

 
Links :
R
SPC
Status :
Non Formulary
Restrictions / Comments:

Important

NHSE commissioned services only. This is NOT commissoned from any Surrey Heartlands Trusts. 

 
Links :
NHSE
SPC
Status :
Red
Formulations :
  • Intravenous infusion
Restrictions / Comments:

Important

Off-label use. For ITU administration via Aerogen nebuliser system.

 
Links :
Off Label
SPC
Status :
Red
Formulations :
  • Intravenous infusion
Restrictions / Comments:

Important

ITU use only - during renal dialysis if heparin is not suitable

 
Links :
R
SPC
Status :
Red
Formulations :
  • Intravenous infusion
Restrictions / Comments:

Important

ITU use only - in patients too unstable for transfer to tertiary care.
Not for routine use - commissioned by NHSE from specialist centres only.

 
Links :
R
SPC
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

Important
Specialist centres only
 
Links :
NHSE
SPC
Indication :
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
Status :
Non Formulary
Restrictions / Comments:

 
Links :
NFD1
SPC
Indication :
Status :
Red
Formulations :
  • Intravenous infusion
Restrictions / Comments:

 
Links :
Status :
Non Formulary
Formulations :
  • Tablets
Restrictions / Comments:

Important
Not licensed for this indication - refer to guidelines for alternatives
 
Links :
Guidelines
NFD1
Off Label
SPC
Indication :
Status :
Red
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

Preferred
 
Links :
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

Important

On advice from specialist.

NHSE do not recommend the routine prescription of vitamins and mineral preparations, with the exceptions of patients with medically diagnosed deficiency, including those with lifelong or chronic conditions, or post surgery resulting in malabsorption (e.g.  Whipple’s procedure and some other GI surgeries), calcium and vitamin D for osteoporosis, prescription-only vitamin D analogues or malnutrition. Continuing need should be reviewed on a regular basis. Not for use for prevention of deficiency  

 
Links :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important

Prevention or treatment of vitamin D deficiency caused by intestinal malabsorption, chronic liver disease or renal failure  (under expert supervision)

 
Links :
Indication :
Status :
Red
Formulations :
  • Infusion
Restrictions / Comments:

Important
Restricted Antimicrobial - requires Microbiology Specialist Approval.
 
Links :
R
SPC
74. Ertugliflozin
Drug:
Ertugliflozin
(Antidiabetic drugs)
Indication :
Status :
Green (see narrative)
Formulations :
  • Tablets
Restrictions / Comments:

Important
Empagliflozin is the preferred SGLT-2. Ertugliflozin is a treatment option. Trusts restrict to diabetic team initiation only.
 
Links :
Indication :
Status :
Green
Formulations :
  • Oral solution
  • Tablets
Restrictions / Comments:

Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines, NICE condensed summary table of antimicrobial guidance or specialist microbiology recommendation. Follow local guidelines on the use of antimicrobials.
 
Links :
R
SPC
Indication :
Status :
Red
Formulations :
  • Infusion
Restrictions / Comments:

Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation. Follow local guidelines on the use of antimicrobials.
 
Links :
R
SPC
Indication :
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

Important
Subject to NICE TA854
 
Links :
Indication :
Status :
Amber
Formulations :
  • Tablets
Restrictions / Comments:

Important
Only when 1st-line and 1st-line adjunctive agents have been unsuccessful
 
Links :
R
SPC
Indication :
Status :
Red
Formulations :
  • Injection
  • Intravenous infusion
Restrictions / Comments:

Important
Restricted to cardiology / Theatres / ITU / Resus
 
Links :
SPC
Status :
Green (see narrative)
Formulations :
  • Capsules
Restrictions / Comments:

Important
Lansoprazole capsules are the preferred option. Esomeprazole 40mg restricted to short-term use or for Zollinger-Ellison syndrome.
 
Links :
Status :
Green (see narrative)
Formulations :
  • Granules
Restrictions / Comments:

Important
Lansoprazole oro-dispersible 1st-line. Esomeprazole is 3rd-line. Restricted to patients with swallowing difficulties or with large bore enteral feeding tube when other options are not clinically appropriate. Do not use in tubes less than 6F.
 
Links :
Status :
Non Formulary
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
Status :
Green (see narrative)
Formulations :
  • Granules
Restrictions / Comments:

Important
Branded Nexium granules for children/infants with enteral feeding tubes (6Fr or larger). Off-label use in infants under 1 year. Generic granules 3rd line in children/infants under 1 year without an NG tube. Refer to PPI algorithm for details.
 
Links :
Indication :
Status :
See narrative
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important
Preferred
Elleste Solo tablets - 1st line
 
Links :
Indication :
Status :
Green
Formulations :
  • Patches
Restrictions / Comments:

Important
Estradiol patches 2nd line to tablets. No preferred patch recommendation has been made due to current stock shortages (Estraderm, Estradot, Evorel, FemSeven, Progynova TS)
 
Links :
Indication :
Status :
Green
Formulations :
  • Spray
Restrictions / Comments:

Important
Lenzetto spray. Caution with higher than licensed doses. Max supply of 20 containers per year to stay within licensed dose.
 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Gel
Restrictions / Comments:

Important
Oestrogel is the preferred gel option. Sandrena is an alternative option.
 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Tablets
Restrictions / Comments:

Important
Progynova and Zumenon tablets NOT 1st line. Only prescribe where Elleste Solo tablets are unavailable.
 
Links :
Status :
Green
Formulations :
  • Patches
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Status :
Amber
Formulations :
  • Gel
  • Patches
  • Tablets
Restrictions / Comments:

 
Links :
Guidelines
Off Label
SPC
Status :
Amber
Formulations :
  • Patches
  • Tablets
Restrictions / Comments:

 
Links :
Guidelines
Off Label
SPC
Indication :
Status :
Green
Formulations :
  • Vaginal tablets
Restrictions / Comments:

Important
Prescribe 10mcg vaginal tablets generically
 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Vaginal ring
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important
Preferred
Femoston tablets - 1st line for women requiring sequential combined therapy.
 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important
Preferred
Femoston Conti - 1st line for women requiring continuous combined therapy.
 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Patches
Restrictions / Comments:

Important
Femseven Conti patches - less preferred. Only use in the event of product shortages.
 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Tablets
Restrictions / Comments:

Important
Tridestra tablets - consider changing to a newer, 1st or 2nd line option.
 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Tablets
Restrictions / Comments:

Important
Indivina tablets - consider changing to a newer, 1st or 2nd line option.
 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Tablets
Restrictions / Comments:

Important

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Not recommended for new initiations. Existing patients may remain on this brand.

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Patches
Restrictions / Comments:

Important
Evorel Sequi patches 2nd-line. Preferred option in women with risk factors for VTE or migraine.
 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Tablets
Restrictions / Comments:

Important
Elleste Duet tablets 2nd line. For women requiring sequential combined therapy but with poor cycle control on Femoston (1st-line).
 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Tablets
Restrictions / Comments:

Important
Novofem tablets - Only use if there are product shortages with Elleste Duet
 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Tablets
Restrictions / Comments:

Important
Elleste Duet Conti - 2nd line for women requiring continuous combined therapy but with poor cycle control on Femoston Conti (1st-line).
 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Patches
Restrictions / Comments:

Important
Evorel Conti patches - preferred in women with risk factors for VTE or migraine. Otherwise use a 1st-line oral option.
 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Tablets
Restrictions / Comments:

Important
Kliofem tablets - 2nd line in women requiring continuous combined therapy but with poor cycle control on Femoston Conti (1st-line)
 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Tablets
Restrictions / Comments:

Important
Kliovance tablets - 2nd line in women requiring continuous combined therapy but with poor cycle control on Femoston Conti (1st-line)
 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Tablets
Restrictions / Comments:

Important
Trisequens tablets - consider changing to newer, 1st or 2nd line options.
 
Links :
Indication :
Status :
Green
Formulations :
  • Capsules
Restrictions / Comments:

Important
Preferred
Bijuve capsules - 1st line for women requiring continuous combined therapy.
 
Links :
Status :
Red
Formulations :
  • Cream
Restrictions / Comments:

Important

Estriol 0.1% cream

 
Links :
Off Label
SPC
Indication :
Status :
Green
Formulations :
  • Vaginal cream
Restrictions / Comments:

Important
Estriol vaginal cream 0.1%
 
Links :
SPC
Indication :
Status :
Green (see narrative)
Formulations :
  • Vaginal gel
Restrictions / Comments:

Important
Estriol (Blissel) vaginal gel is reserved for women who do not tolerate estriol vaginal cream or estradiol pessaries
 
Links :
R
SPC
Indication :
Status :
Non Formulary
Formulations :
  • Vaginal cream
Restrictions / Comments:

Important
Estriol vaginal cream 0.01% is non-formulary
 
Links :
SPC
Indication :
Status :
Non Formulary
Formulations :
  • Vaginal tablets
Restrictions / Comments:

Important
Estriol 500mcg vaginal tablets are non-formulary.
 
Links :
SPC
Indication :
Status :
Non Formulary
Formulations :
  • Pessaries
Restrictions / Comments:

Important
Estriol pessaries (Imvaggis) are non-formulary.
 
Links :
SPC
Indication :
Status :
Non Formulary
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
NFD2
SPC
Indication :
Status :
Red
Restrictions / Comments:

Important
Unlicensed. Short term use for menorrhagic blood loss.
 
Links :
SPC
Status :
Red
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

 
Links :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

Important
Prescribe by brand. ICB commissioned in patients after 18 years of age
 
Links :
ICB
NICE
Off Label
SPC
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

Important
Prescribe by brand. NHSE commissioned in patients under 18 years of age
 
Links :
NHSE
NICE
Off Label
SPC
Indication :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
ICB
NICE
SPC
Indication :
Status :
Red
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

 
Links :
ICB
NICE
SPC
Indication :
Status :
Red
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

 
Links :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

Important
Specialist centres only
 
Links :
NHSE
SPC
Indication :
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
See narrative
Formulations :
  • Gel
Restrictions / Comments:

Important

Not assessed for inclusion on the formulary. Contact pharmacy team for advice on making an application.

 
Links :
Status :
Red
Formulations :
  • Intravenous injection (IV)
Restrictions / Comments:

Important

Fomepizole is the treatment of choice for ethylene glycol and methanol (methyl alcohol) poisoning. If necessary, ethanol (by mouth or by intravenous infusion) can be used, but with caution. https://www.toxbase.org/

 
Links :
SPC
Indication :
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
Status :
Amber
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
Guidelines
Off Label
SPC
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important
Preferred

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Preferred brands: Gedarel 20/150, Bimezza, Gedarel 30/150, Cimizt

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Tablets
Restrictions / Comments:

Important

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Mercilon, Marvilon - Not recommended for new initiations. Exisitng patients may remain on this brand.

 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important
Preferred

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Preferred brands: Yacella, Dretine

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Tablets
Restrictions / Comments:

Important

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Lucette, Ellanite, Yasmin, Eloine - Not recommended for new initiations. Exisitng patients may remain on this brand.

 
Links :
Indication :
Status :
Green
Formulations :
  • Vaginal insert
Restrictions / Comments:

Important

Note a cost-effective choice. Consider only if compliance / swallowing difficulties / malabsorption with oral CHC and LARC is unsuitable.

SyreniRing is lower cost than NuvaRing and does not require refrigeration

 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important
Preferred

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Preferred brands: Millinette 20/75, Millinette 30/75

 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Sunya, Akizza 75/20, Katya

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Tablets
Restrictions / Comments:

Important

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Femodette, Femodene, Akizza 75/30 - Not recommended for new initiations. Exisitng patients may remain on this brand.

 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important
Preferred

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Preferred brands = Levest, Rigevidon, Maexeni,

 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Microgynon 30 ED, TriRegol, Logynon, Logynon ED

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Tablets
Restrictions / Comments:

Important

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Ovranette / Ambelina / Microgynon 30 - not for new initiations. Existing patients may remain on current brand.

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Tablets
Restrictions / Comments:

Important

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Elevin brand is not a cost effective option. 

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Patches
Restrictions / Comments:

Important

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

Not a cost-effective choice. Consider only if compliance issues/swallowing difficulties/malabsorption with oral CHC and LARC is unsuitable.

 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important

NOTE - Trusts are unlikely to initiate oral contraceptives but will obtain supplies for the continuation of treatment during in-patient episodes.

 
Links :
Indication :
Status :
Blue
Formulations :
  • Capsules
  • Oral solution
Restrictions / Comments:

Important
For absence, atypical and myoclonic seizures
 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Spray
Restrictions / Comments:

Important

RSFT for:

  • Topical Cryoanaesthesia
  • Assessment of neuroaxial block immediately before a procedure
 
Links :
R
SPC
Status :
Non Formulary
Restrictions / Comments:

 
Links :
NFD1
SPC
Indication :
Status :
Green
Formulations :
  • Implant
Restrictions / Comments:

 
Links :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important
Acute gout, gouty arthritis
 
Links :
SPC
Status :
Green (see narrative)
Formulations :
  • Tablets
Restrictions / Comments:

Important

2nd line COXX II except for gouty arthritis where etoricoxib is the preferred COX II

 
Links :
SPC
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

Important
Ulcerative colitis only
NICE guidance applies to Ulcerative Colitis patients only
 
Links :
Status :
Red
Formulations :
  • Intravenous infusion
Restrictions / Comments:

Important

NHSE Specialist Commissioned centres only.

 
Links :
NHSE
SPC
Status :
Red
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

Important
NHSE Specialist Commissioned centres only
 
Links :
NHSE
SPC
Indication :
Status :
Red
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

Important
Restricted to lipidologists only for heterozygous familial and non-familial hypercholesterolaemia.
 
Links :
Indication :
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

Important

1st month supply from specialist team before request for primary care prescribing

 
Links :
SPC
156. Exenatide
Drug:
Exenatide
(Antidiabetic drugs)
Indication :
Status :
Green (see narrative)
Formulations :
  • Not Specified
Restrictions / Comments:

Important
Exenatide is not a preferred treatment option. The preferred GLP-1 for WEEKLY injection is dulaglutide. Prescribing may continue on existing patients.
 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :